Syneos Health Consulting Releases 11th Annual Survey of Biopharmaceutical Dealmakers
June 05, 2019 12:15 ET
|
Syneos Health, Inc.
PHILADELPHIA, June 05, 2019 (GLOBE NEWSWIRE) -- The 11th annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading biopharmaceutical management consulting firm,...
Syneos Health Consulting Releases 10th Annual Biopharmaceutical Dealmakers Survey – Predicts M&A Landscape to Continue Bull Run, While Buyers Begin to Become More Risk Averse
June 05, 2018 16:00 ET
|
Syneos Health
BOSTON, June 05, 2018 (GLOBE NEWSWIRE) -- The tenth annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading consulting firm specializing in the biopharmaceutical...
Syneos Health to Present Actionable Commercial Insights Designed for Biopharmaceutical Companies at BIO International Convention
June 05, 2018 08:55 ET
|
Syneos Health
RALEIGH, N.C., June 05, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and...